EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Hearing Improvement after Radiation Therapy for a Facial Nerve Schwannoma: Report of a Case and Review of Literature

Isabella L Pecorari iD, Sayak R Ghosh, Howard S Moskowitz, Vijay Agarwal

Journal of Neurological Surgery Reports · 01.07.2024 · 85 (03) · e112-e117

DOI: 10.1055/s-0044-1788071 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Neurological Surgery Reports, erschienen am 01.07.2024. Verfasst von Isabella L Pecorari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, Albert Einstein College of Medicine, Bronx, New York, United States. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

While facial nerve schwannomas are considered benign, they can impart various significant clinical effects due to pressure on nearby cerebrovascular structures within the cerebellopontine angle (CPA). Although surgical resection and/or radiation therapy often provide definitive treatment of such tumors, posttreatment hearing loss is a common finding. In this report, we present the case of a patient with a facial nerve schwannoma successfully treated with radiotherapy with resultant hearing improvement, an extremely rare clinical finding. Case Presentation A 63-year-old woman presented with a 1-year history of progressively worsening hearing loss and tinnitus. Brain imaging demonstrated an enhancing lesion of the right CPA measuring 2.7 × 2.1 × 3.1 cm. Pretreatment audiometry evaluation revealed sensorineural hearing loss in the right ear with a pure-tone average (PTA) of 74 dB, speech threshold (ST) of 75 dB, and speech discrimination (SD) of 0%. The patient proceeded with attempted surgical resection, aborted due to significant facial nerve stimulation, and ultimately underwent radiation therapy (50.4 Gy, 28 fractions). At the 1-year follow-up visit, the patient reports subjective hearing loss resolution with PTA of 34 dB, 30 dB ST, and 88% SD on audiological evaluation.

Conclusion

Although radiation therapy for schwannomas within the CPA has historically been associated with hearing loss, fractionated stereotactic radiotherapy (FSRT) may provide improved clinical outcomes compared with high-dose radiosurgery. Given the effectiveness of this treatment modality and improved quality of life offered to patients over surgery, FSRT may be considered an initial management option for patients with facial nerve schwannomas.

Schlagwörter

Stichwörter der Autor:innen

CPA massfacial nerve schwannomahearing improvementradiation therapy

Autor:innen und Institutionen

  • Department of Neurological Surgery, Albert Einstein College of Medicine, Bronx, New York, United States.
  • Department of Neurological Surgery, Montefiore Medical Center, Bronx, New York, United States.
  • Department of Otorhinolaryngology, Albert Einstein College of Medicine, Bronx, New York, United States.
  • Department of Otorhinolaryngology, Montefiore Medical Center, Bronx, New York, United States.

ORCID-Profile: Isabella L Pecorari

Zitieren

APA

Pecorari, I. L., Ghosh, S. R., Moskowitz, H. S., & Agarwal, V. (2024). Hearing Improvement after Radiation Therapy for a Facial Nerve Schwannoma: Report of a Case and Review of Literature. Journal of Neurological Surgery Reports, 85(03), e112-e117. https://doi.org/10.1055/s-0044-1788071

Vancouver

Pecorari IL, Ghosh SR, Moskowitz HS, Agarwal V. Hearing Improvement after Radiation Therapy for a Facial Nerve Schwannoma: Report of a Case and Review of Literature. Journal of Neurological Surgery Reports. 2024;85(03):e112-e117. doi:10.1055/s-0044-1788071

BibTeX
@article{Pecorari2024,
  author = {Pecorari, Isabella L and Ghosh, Sayak R and Moskowitz, Howard S and Agarwal, Vijay},
  title = {Hearing Improvement after Radiation Therapy for a Facial Nerve Schwannoma: Report of a Case and Review of Literature},
  journal = {Journal of Neurological Surgery Reports},
  year = {2024},
  volume = {85},
  number = {03},
  pages = {e112--e117},
  doi = {10.1055/s-0044-1788071}
}
Kostenlos starten →